The EPOC database was locked on 31 May 2013 following receipt of all the CRFs and answering of all data queries. The final analyses of data for both doxorubicin and the major metabolite doxrubicinol are now nearing completion.
Last modified: Wed, 25 Sep 2013 09:57:47 BST
ZKS Münster have started to perform the close-out monitoring visits for all the clinical sites which have taken part in the EPOC-doxorubicin study. Clinical centres are requested to send the completed CRFs to Münster without delay.
Last modified: Wed, 20 Mar 2013 11:59:25 GMT
EPOC-doxorubicin newsletter January 2013
The target of 100 patients has now been reached and the EPOC-doxorubicin study is closed to recruitment.
Last modified: Wed, 20 Mar 2013 11:59:02 GMT